Key result
Continuous renal replacement therapy, ammonia scavengers, and protein restriction successfully resolved life-threatening hyperammonemia and cerebral edema in a 48-year-old man with HHH syndrome.
Case Report (n=1)
Rare metabolic genetic disorders such as urea cycle disorders should be considered in adult patients presenting with prolonged unexplained unconsciousness.
Answers are grounded in this paper and cite their sources.
May warrant HHH syndrome consideration in unexplained adult hyperammonemia; leaves open prevalence and diagnostic algorithms.
BACKGROUND: Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a rare inherited urea cycle disorder, can remain undiagnosed for decades and suddenly turn into an acute life-threatening state. Adult presentation of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome has rarely been described, but is potentially underdiagnosed in the emergency room. In the case of acute hyperammonemia, prompt diagnosis is essential to minimize the risk of brain damage and death. CASE PRESENTATION: We present the diagnostics, clinical course, and treatment of a 48-year-old Caucasian man presenting with unexplained unconsciousness in the emergency room. A web search by a family member led to the suspicion of urea cycle disorder. Subsequent analysis of plasma ammonia and amino acids in plasma and urine demonstrated a pattern typical for hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. The diagnosis was confirmed by genetic analysis which revealed two heterozygous mutations in the SLC25A15 gene. The cause of the hyperammonemia crisis was acute upper gastrointestinal hemorrhage, leading to protein overload and subsequent cerebral edema. Continuous renal replacement therapy, scavenger treatment, and tightly controlled nutrition were useful in preventing hyperammonemia and recurrence of cerebral edema. CONCLUSIONS: The case emphasizes the importance of taking rare metabolic genetic disorders into consideration in patients with prolonged unexplained unconsciousness.
No takes yet. Share an insight, caveat, or question.
Sahlander et al. (2018) conducted a case report in Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (n=1). Continuous renal replacement therapy, scavenger treatment, and controlled nutrition was evaluated on Plasma ammonia levels and clinical recovery. Continuous renal replacement therapy, ammonia scavengers, and protein restriction successfully resolved life-threatening hyperammonemia and cerebral edema in a 48-year-old man with HHH syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: